Camille Locht (C Locht)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Escherichia Coli

Dendritic Cells

Risk Assessment

Top Venues

Human vaccines & immunotherapeutics

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Paulo Renato Zuquim Antas, Mario Alberto Flores-Valdez, Camille Locht
Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix? Human vaccines & immunotherapeutics 20 (1) (2024)
Paulo Renato Zuquim Antas, Mario Alberto Flores-Valdez, Camille Locht
Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix? Human vaccines & immunotherapeutics 20 (1) (2024)
Paulo Renato Zuquim Antas, Mario Alberto Flores-Valdez, Camille Locht
Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix? Human vaccines & immunotherapeutics 20 (1) (2024)
Paulo Renato Zuquim Antas, Mario Alberto Flores-Valdez, Camille Locht
Revamping the BCG revaccination strategy: Records to recall, or just call it phoenix? Human vaccines & immunotherapeutics 20 (1) (2024)
Françoise Mascart, Maya Hites, Emmanuelle Watelet, Gil Verschelden, Christelle Meuris, Jean-Luc Doyen, Anne Van Praet, Audrey Godefroid, Emmanuelle Petit, Mahavir Singh, Camille Locht, Véronique Corbière
Analysis of a Combined HBHA and ESAT-6-Interferon-γ-Release Assay for the Diagnosis of Tuberculous Lymphadenopathies. Journal of clinical medicine 12 (6) (2023)
Camille Locht
Pasteurian Contributions to the Study of Bordetella pertussis Toxins. Toxins 15 (3) (2023)
Camille Locht
Pasteurian Contributions to the Study of Bordetella pertussis Toxins. Toxins 15 (3) (2023)
Françoise Mascart, Maya Hites, Emmanuelle Watelet, Gil Verschelden, Christelle Meuris, Jean-Luc Doyen, Anne Van Praet, Audrey Godefroid, Emmanuelle Petit, Mahavir Singh, Camille Locht, Véronique Corbière
Analysis of a Combined HBHA and ESAT-6-Interferon-γ-Release Assay for the Diagnosis of Tuberculous Lymphadenopathies. Journal of clinical medicine 12 (6) (2023)
Françoise Mascart, Maya Hites, Emmanuelle Watelet, Gil Verschelden, Christelle Meuris, Jean-Luc Doyen, Anne Van Praet, Audrey Godefroid, Emmanuelle Petit, Mahavir Singh, Camille Locht, Véronique Corbière
Analysis of a Combined HBHA and ESAT-6-Interferon-γ-Release Assay for the Diagnosis of Tuberculous Lymphadenopathies. Journal of clinical medicine 12 (6) (2023)
Camille Locht
Pasteurian Contributions to the Study of Bordetella pertussis Toxins. Toxins 15 (3) (2023)
Magdalena Kowalewicz-Kulbat, Camille Locht
Recombinant BCG to Enhance Its Immunomodulatory Activities. Vaccines 10 (5) (2022)
Thomas Belcher, Saliha Ait-Yahia, Luis Solans, Anne-Sophie Debrie, Stephane Cauchi, Anne Tsicopoulos, Camille Locht
Live attenuated pertussis vaccine for prevention and treatment of allergic airway inflammation in mice. NPJ vaccines 7 (1) (2022)
Camille Locht, Rudy Antoine
The History of Pertussis Toxin. Toxins 13 (9) (2021)
Loic Coutte, Rudy Antoine, Stephanie Slupek, Luis Solans, Julien Derop, Amélie Bonnefond, David Hot, Camille Locht
Combined RNAseq and ChIPseq Analyses of the BvgA Virulence Regulator of Bordetella pertussis. mSystems 5 (3) (2020)
Camille Locht, Maria Lerm
Good old BCG - what a century-old vaccine can contribute to modern medicine. Journal of internal medicine 288 (6) (2020)